4.6 Article

Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Significance of metallothioneins in aging brain

Sushil Sharma et al.

NEUROCHEMISTRY INTERNATIONAL (2014)

Review Neurosciences

The serotonergic system in motor and non-motor manifestations of Parkinson's disease

Philippe Huot et al.

EXPERIMENTAL BRAIN RESEARCH (2013)

Article Neurosciences

Network effects of subthalamic deep brain stimulation drive a unique mixture of responses in basal ganglia output

Mark D. Humphries et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2012)

Article Clinical Neurology

Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson's disease

K. Ishibashi et al.

ACTA NEUROLOGICA SCANDINAVICA (2010)

Review Clinical Neurology

Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease

Claire L. Tomlinson et al.

MOVEMENT DISORDERS (2010)

Review Clinical Neurology

Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease

Alim Louis Benabid et al.

LANCET NEUROLOGY (2009)

Article Clinical Neurology

Inter- and intra-individual variation in L-dopa pharmacokinetics in the treatment of Parkinson's disease

Masahiro Nomoto et al.

PARKINSONISM & RELATED DISORDERS (2009)

Review Neurosciences

Translational principles of deep brain stimulation

Morten L. Kringelbach et al.

NATURE REVIEWS NEUROSCIENCE (2007)

Article Biochemistry & Molecular Biology

Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons

SK Sharma et al.

ANTIOXIDANTS & REDOX SIGNALING (2003)

Article Pharmacology & Pharmacy

Sources and significance of plasma levels of catechols and their metabolites in humans

DS Goldstein et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY